According to the latest research report titled ‘Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential’, available with Market Study Report, global human vaccines market size is expected to record an appreciable growth rate throughout 2019-2025.
 

As per the findings of the report, growing awareness regarding various diseases coupled with rising emphasis on immunization programs is fostering global human vaccines market growth. More importantly, increasing approval/launches of new vaccines, and supportive government policies & initiatives are accelerating the industry expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2245930/
 

The research document divides the industry into several segments, including disease, end-user, and leading vaccine.
 

Based on disease, global human vaccines market is fragmented into varicella, rotavirus, measles, mumps, and rubella (MMR), hepatitis, meningococcal, human papilloma virus (HPV), influenza, diphtheria, tetanus and pertussis (DTP), pneumococcal disease, and others.
 

In terms of end-user spectrum, the industry is split into adult vaccines and pediatric vaccines.
 

Considering the leading vaccines, global human vaccines industry is segmented into Imvamune, Anflu, EasySix, BiLive, InLive, HeaLive, Ixiaro, BioThrax, Dukoral, Flumist/Fluenz, Varicella (MTP), Jebik V, Mearubik, Biken Ha, Tetrabik, Pediarix, Infanrix, Ticovac, Synflorix, Zostavax, Rotarix, Pentacel, Pentaxim, Imovax, Hexaxim, Rotateq, Shingrix, Cervarix, Trumenba, Menveo, Boostrix, Bexsero, Adacel, M-M-R II, Priorix, Priorix Tetra, Varilrix, Fluarix/FluLaval, Havrix/Twinrix/Engerix-B, 7.8 Proquad, Pneumovax 23, Menactra, Varivax, Flublok, Vaxigrip, Fluzone, Prevnar / Prevnar 13, and Gardasil / Gardasil 9.
 

Speaking of the competitive arena, top contenders in global human vaccines market sphere are Biological E. Limited, Serum Institute of India, Bharat Biotech International Ltd., Panacea Biotec, Sinovac Bitotech, Bavarian Nordic A/S, Valneva SE, Astellas Pharma, Inc., Emergent Biosolutions, Inc., Mitsubishi Tanabe Pharma Corp., AstraZeneca plc, Pfizer, Inc., Merck Group, GlaxoSmithKline plc, and Sanofi S.A.